Skip to content
Parakho

Hikal Ltd

NSE HIKALBSE 524735hikal.com

Q1 FY27, unaudited

Revenue
₹402.80 Cr
Profit after tax
₹-7.40 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations402.80+5.89%1,712.60
Other income1.80+80.00%12.30
Total income404.60+6.08%1,724.90
Employee benefit expense74.40+18.28%270.30
Finance costs14.90−12.87%62.10
Depreciation & amortisation42.70+8.38%163.80
Total expenses423.40+2.82%1,718.10
Profit before tax-9.90+67.43%-78.30
Tax expense-2.50+68.75%-29.50
Profit after tax-7.40+66.96%-48.80
Total comprehensive income-7.20+68.42%-51.20
Earnings per share
Earnings per share, basic₹-0.60₹-3.96
Earnings per share, diluted₹-0.60₹-3.96

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Hikal reported Q4 FY26 revenue of INR519 crores with EBITDA margin at 20.3%, while full-year FY26 revenue stood at INR1,713 crores with EBITDA margin at 12.9%. Management attributed the quarterly improvement to recovery in Pharma demand trends and a rebound in Crop Protection volumes following industry inventory correction, while noting an exceptional impairment charge of INR47 crores on a multipurpose manufacturing facility at Panoli. Management also discussed an ongoing US FDA warning letter affecting the Bangalore pharma site, which slowed shipments and production in the year, alongside continued investment in CDMO, HPAPI and Animal Health capabilities.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 37 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 12 Aug 2026.